Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)

Yazar
Mandel, Nil
Yildiz, Ozcan
Yanmaz, Teoman
Serdengecti, Suheyla
Ozguroglu, Mustafa
Evrensel, Turkkan
Er, Ozlem
Turna, Hande
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/159923
Koleksiyonlar